Surgery for Pulmonary Aspergilloma in Immunocompetent Patients: No Benefit From Adjuvant Antifungal Pharmacotherapy

Annals of Thoracic Surgery

Volumn 89, Issue 5, 2010, Pages 1603-1610

  Sagan, Dariusz ^a   Goździuk, Kazimierz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; ITRACONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ARTICLE; ASPERGILLOMA; ATELECTASIS; BRONCHOPLEURAL FISTULA; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOCOMPETENCE; KIDNEY DYSFUNCTION; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; NEPHROTOXICITY; NERVE PARALYSIS; PLEURA EMPYEMA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX RATIO; SUPPURATION; SURVIVAL; TREATMENT OUTCOME; ADOLESCENT; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; HOSPITALIZATION; IMMUNOLOGY; KAPLAN MEIER METHOD; LUNG ASPERGILLOSIS; LUNG RESECTION; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PERIOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPETENCE; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE CARE; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; PULMONARY ASPERGILLOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953032923     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.02.037     Document Type: Article

References (38)

1. Lee J.G., Lee C.Y., Park I.K., et al. Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment. J Thorac Cardiovasc Surg 138 (2009) 820-825
2. Brik A., Salem A.M., Kamal A.R., et al. Surgical outcome of pulmonary aspergilloma. Eur J Cardiothorac Surg 34 (2008) 882-885
3. Park C.K., and Jheon S. Results of surgical treatment for pulmonary aspergilloma. Eur J Cardiothorac Surg 21 (2002) 918-923
4. Akbari J.G., Varma P.K., Neema P.K., Menon M.U., and Neelakandhan K.S. Clinical profile and surgical outcome for pulmonary aspergilloma: a single center experience. Ann Thorac Surg 80 (2005) 1067-1072
5. Campbell J.H., Winter J.H., Richardson M.D., Shankland G.S., and Banham S.W. Treatment of pulmonary aspergilloma with itraconazole. Thorax 46 (1991) 839-841
6. Stevens D.A., Kan V.L., Judson M.A., et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 30 (2000) 696-709
7. Hammerman K.J., Sarosi G.A., and Tosh F.E. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis. Am Rev Respir Dis 109 (1974) 57-62
8. Jewkes J., Kay P.H., Paneth M., and Citron K.M. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 38 (1983) 572-578
9. Battaglini J.W., Murray G.F., Keagy B.A., Starek P.J., and Wilcox B.R. Surgical management of symptomatic pulmonary aspergilloma. Ann Thorac Surg 39 (1985) 512-516
10. Belcher J.R., and Plummer N.S. Surgery in broncho-pulmonary aspergillosis. Br J Dis Chest 54 (1960) 335-341
11. Babatasi G., Massetti M., Chapelier A., et al. Surgical treatment of pulmonary aspergilloma: current outcome. J Thorac Cardiovasc Surg 119 (2000) 906-912
12. Seki M., Maesaki S., Hashiguchi K., et al. Aspergillus fumigatus isolated from blood samples of a patient with pulmonary aspergilloma after embolization. Intern Med 39 (2000) 188-190
13. Saito T., Shime N., Itoh K., et al. Disseminated Aspergillosis following resolution of pneumocystis pneumonia with sustained elevation of beta-glucan in an intensive care unit: a case report. Infection 37 (2009) 547-550
14. Ho K.M., Lipman J., Dobb G.J., and Webb S.A. The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis. Crit Care 9 (2005) R710-R717
15. Calandra T., and Marchetti O. Clinical trials of antifungal prophylaxis among patients undergoing surgery. Clin Infect Dis 39 suppl 4 (2004) S185-S192
16. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17 (1998) 857-872
17. Kauffman C.A. Quandary about treatment of aspergillomas persists. Lancet 347 (1996) 1640
18. Kawamura S., Maesaki S., Tomono K., Tashiro T., and Kohno S. Clinical evaluation of 61 patients with pulmonary aspergilloma. Intern Med 39 (2000) 209-212
19. British Thoracic and Tuberculosis Association. Aspergilloma and residual tuberculous cavities: the results of re-survey. Tubercle 51 (1970) 227-245
20. el Oakley R., Petrou M., and Goldstraw P. Indications and outcome of surgery for pulmonary aspergilloma. Thorax 52 (1997) 813-815
21. Jewkes J., Kay P.H., Paneth M., and Citron K.M. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 38 (1983) 572-578
22. Karas A., Hankins J.R., Attar S., Miller J.E., and McLaughlin J.S. Pulmonary aspergillosis: an analysis of 41 patients. Ann Thorac Surg 22 (1976) 1-7
23. Chun J.Y., and Belli A.M. Immediate and long-term outcomes of bronchial and non-bronchial systemic artery embolisation for the management of haemoptysis. Eur Radiol 20 (2009) 558-565
24. Dagenais T.R., and Keller N.P. Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis. Clin Microbiol Rev 22 (2009) 447-465
25. Hasosah M.Y., and Enemuo V. Invasive gastrointestinal aspergillosis in an immunocompromised host. Saudi Med J 30 (2009) 439-440
26. Schwartz S., and Thiel E. Cerebral aspergillosis: tissue penetration is the key. Med Mycol 47 suppl 1 (2009) S387-S393
27. Lim K.K., Kaye A.H., and Drummond K.J. Cerebral aspergillosis complicated by intracerebral haemorrhage. J Clin Neurosci 16 (2009) 140-142
28. Kohno S. High mortality in invasive aspergillosis: what we need to know for determination of poor prognosis and next countermeasures. Clin Infect Dis 47 (2008) 1185-1187
29. Giron J., Poey C., Fajadet P., et al. CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases. Eur J Radiol 28 (1998) 235-242
30. Mori T., Ebe T., Isonuma H., et al. Aspergilloma: comparison of treatment methods and prognoses. J Infect Chemother 6 (2000) 233-239
31. Maesaki S., Kohno S., Kaku M., Koga H., and Hara K. Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus. Antimicrob Agents Chemother 38 (1994) 2843-2845
32. Chow L., Brown N.E., and Kunimoto D. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis. Clin Infect Dis 35 (2002) e106-e110
33. Pakyz A., and Bearman G. Adverse drug events complicate antifungal therapy for pulmonary aspergilloma. Consult Pharm 23 (2008) 804-808
34. Bellete B., Raberin H., Morel J., Flori P., Hafid J., and Sung R.T. Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma. Med Mycol 19 (2009) 1-4 Feb
35. Eastridge C.E., Young J.M., Cole F., Gourley R., and Pate J.W. Pulmonary aspergillosis. Ann Thorac Surg 13 (1972) 397-403
36. Gebitekin C., Sami Bayram A., and Akin S. Complex pulmonary aspergilloma treated with single stage cavernostomy and myoplasty. Eur J Cardiothorac Surg 27 (2005) 737-740
37. Chen J.C., Chang Y.L., Luh S.P., Lee J.M., and Lee Y.C. Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax 52 (1997) 810-813
38. Kawana A., Yamauchi Y., and Kudo K. Anti-fungal chemotherapy for symptomatic pulmonary aspergilloma. Jpn J Infect Dis 53 (2000) 29-30